Fennec Pharmaceuticals Inc.
Cash Flow History
| Fiscal Year | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| FY2011 | $-3.2M | $-3.2M | $0 | $129.0K |
| FY2012 | $-3.0M | $-3.0M | $0 | $174.0K |
| FY2013 | $-2.2M | $-2.2M | $0 | $62.0K |
| FY2014 | $-1.7M | $-1.7M | — | $627.0K |
| FY2015 | $-1.9M | $-1.9M | — | $97.0K |
| FY2016 | $-2.1M | $-2.1M | — | $615.0K |
| FY2017 | $-3.6M | $-3.6M | — | $1.5M |
| FY2018 | $-7.8M | $-7.8M | — | $1.8M |
| FY2019 | $-9.1M | $-9.1M | — | $2.7M |
| FY2020 | $-15.6M | $-15.6M | — | $2.8M |
| FY2021 | $-14.2M | $-14.2M | — | $3.7M |
| FY2022 | $-18.1M | $-18.1M | — | $4.1M |
| FY2023 | $-17.1M | $-17.1M | — | $5.4M |
| FY2024 | $27.0M | $27.0M | — | $5.1M |
| FY2025 | $-12.5M | $-12.5M | — | $7.0M |